Marvell Technology, Inc. (MRVL) NASDAQ
208.26
+11.93(+6.08%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
208.26
+11.93(+6.08%)
Currency In USD
| Previous Close | 196.33 |
| Open | 211.25 |
| Day High | 217.45 |
| Day Low | 200.04 |
| 52-Week High | 217.45 |
| 52-Week Low | 58.61 |
| Volume | 41.34M |
| Average Volume | 26.31M |
| Market Cap | 182.34B |
| PE | 68.06 |
| EPS | 3.06 |
| Moving Average 50 Days | 139.91 |
| Moving Average 200 Days | 96.57 |
| Change | 11.93 |
Toronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite
Newsfile
Dec 22, 2025 7:07 PM GMT
Toronto, Ontario--(Newsfile Corp. - December 22, 2025) - Rod Matheson, Chief Executive Officer, and Mark Williams, Chief Strategy Officer, from Marvel Biosciences Corp. (the "Company") (TSXV: MRVL), shares the Company's story in an interview with TMX